<DOC>
	<DOCNO>NCT00795288</DOCNO>
	<brief_summary>The primary objective project investigate effect statin therapy cerebral blood flow patient aneurysmal SAH randomize receive receive statin blind design .</brief_summary>
	<brief_title>Statins Cerebral Blood Flow Subarachnoid Hemorrhage ( SAH )</brief_title>
	<detailed_description>We determine statin therapy improve CBF patient aneurysmal subarachnoid hemorrhage . This improvement , present , may due improve basal CBF , improve autoregulatory function , mitigation large arterial narrowing . The information gain study help u good understand mechanism action statins . This knowledge may useful design future study statins development therapy aim similar mechanism .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Age &gt; 18 SAH rupture cerebral aneurysm within 48 hour admission . Modified Fisher grade 2,3 , 4 Planned surgical endovascular aneurysm repair Pregnancy SAH secondary traumatic mycotic aneurysm Preictal statin therapy Contraindication stain therapy WFNS grade 5 Contraindications MAP elevation day 710</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>vasospasm</keyword>
	<keyword>cerebral blood flow</keyword>
	<keyword>cerebral metabolism</keyword>
	<keyword>autoregulation</keyword>
	<keyword>statin</keyword>
	<keyword>Vasospasm associate Subarachnoid hemorrhage</keyword>
</DOC>